These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 12967337)

  • 21. Interferon-alpha therapy alters glucose metabolism in patients with chronic hepatitis B.
    Tanaka H; Shiota G; Kawasaki H
    J Med; 1997; 28(5-6):325-34. PubMed ID: 9604791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.
    Brändle M; Lehmann R; Maly FE; Schmid C; Spinas GA
    Diabetes Care; 2001 Jul; 24(7):1253-8. PubMed ID: 11423511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon treatment of chronic hepatitis C in patients cured of pediatric malignancies.
    Cesaro S; Bortolotti F; Petris MG; Brugiolo A; Cusinato R; Guido M; Rossetti F; Masiero L; Zanesco L
    Haematologica; 2000 Jan; 85(1):63-6. PubMed ID: 10629594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic alpha-cell function in idiopathic reactive hypoglycemia.
    Ahmadpour S; Kabadi UM
    Metabolism; 1997 Jun; 46(6):639-43. PubMed ID: 9186298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The investigation of glucose metabolism and insulin secretion in subjects of chronic hepatitis B with cirrhosis.
    Guo CH; Sun TT; Weng XD; Zhang JC; Chen JX; Deng GJ
    Int J Clin Exp Pathol; 2015; 8(10):13381-6. PubMed ID: 26722544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C.
    Kawaguchi Y; Mizuta T; Oza N; Takahashi H; Ario K; Yoshimura T; Eguchi Y; Ozaki I; Hisatomi A; Fujimoto K
    Liver Int; 2009 Jul; 29(6):871-7. PubMed ID: 19302179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-cell dysfunction in first-degree relatives of patients with non-insulin-dependent diabetes mellitus.
    Fernández-Castañer M; Biarnés J; Camps I; Ripollés J; Gómez N; Soler J
    Diabet Med; 1996 Nov; 13(11):953-9. PubMed ID: 8946153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Index60 as an additional diagnostic criterion for type 1 diabetes.
    Redondo MJ; Nathan BM; Jacobsen LM; Sims E; Bocchino LE; Pugliese A; Schatz DA; Atkinson MA; Skyler J; Palmer J; Geyer S; Sosenko JM;
    Diabetologia; 2021 Apr; 64(4):836-844. PubMed ID: 33496819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon induces insulin resistance in patients with chronic active hepatitis C.
    Imano E; Kanda T; Ishigami Y; Kubota M; Ikeda M; Matsuhisa M; Kawamori R; Yamasaki Y
    J Hepatol; 1998 Feb; 28(2):189-93. PubMed ID: 9514530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin and C-peptide plasma levels in patients with severe chronic pancreatitis and fasting normoglycemia.
    Bonora E; Rizzi C; Lesi C; Berra P; Coscelli C; Butturini U
    Dig Dis Sci; 1988 Jun; 33(6):732-6. PubMed ID: 3286157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preliminary results of interferon alpha-2a and lamivudine combination therapy regimen in children with chronic hepatitis B].
    Aşik Akman S; Cokçeken Okçu S; Anil OH; Köse S; Bakiler AR
    Mikrobiyol Bul; 2006; 40(1-2):47-53. PubMed ID: 16775956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
    PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y; Kozawa J; Iwahashi H; Yoneda S; Uno S; Yoshikawa A; Okita K; Eguchi H; Nagano H; Imagawa A; Shimomura I
    Endocr J; 2015; 62(4):329-37. PubMed ID: 25740613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?
    Gluhovschi C; Gadalean F; Kaycsa A; Curescu M; Sporea I; Gluhovschi G; Petrica L; Velciov S; Bozdog G; Bob F; Vernic C; Cioca D
    Immunopharmacol Immunotoxicol; 2011 Dec; 33(4):744-50. PubMed ID: 21320001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term effect of alpha interferon in children with chronic hepatitis B.
    Bortolotti F; Jara P; Barbera C; Gregorio GV; Vegnente A; Zancan L; Hierro L; Crivellaro C; Vergani GM; Iorio R; Pace M; Con P; Gatta A
    Gut; 2000 May; 46(5):715-8. PubMed ID: 10764718
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.